Search Results for: New Preclinical Studies Reinforce the
Articles
November 9, 2017
G1 Therapeutics Announces Publication in Cancer Discovery November 9, 2017
G1 Therapeutics, Inc. recently announced the publication CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation, is available online...
November 6, 2017
Citoxlab Acquires American CRO Xenometrics November 6, 2017
Citoxlab Group recently announced the acquisition of Xenometrics, an American CRO specialized in the non-clinical assessment of new drug candidates....
May 30, 2017
Attune Pharmaceuticals Announces Positive Data May 30, 2017
Attune Pharmaceuticals recently announced positive results from preclinical safety studies evaluating ATN-249, a novel orally administered plasma kallikrein inhibitor for...
February 13, 2017
GW Pharmaceuticals Achieves Positive Results in Phase II Study February 13, 2017
GW Pharmaceuticals plc recently announced positive top-line results from an exploratory Phase II placebo-controlled clinical study of a proprietary combination...
November 29, 2012
12/5/2012 November 29, 2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
April 29, 2012
5/1/2012 April 29, 2012
3M DDS to Enhance Manufacturing Capabilities 3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill...
April 29, 2012
Harlan & Ipsen Enter Agreement to Enhance Early Stage Development Services April 29, 2012
Harlan Laboratories Contract Research Services (CRS) and Ipsen, a global specialty-driven pharmaceutical company, recently announced they have strengthened their collaboration...
February 29, 2012
3/6/2012 February 29, 2012
Avanir & Concert Announce Exclusive License Agreement Avanir Pharmaceuticals, Inc. and Concert Pharmaceuticals, Inc. recently announced they have entered into...
August 4, 2011
8/9/2011 August 4, 2011
Celgene & Acceleron Enter Agreement Worth Up to $242 Million Celgene Corporation and Acceleron Pharma, Inc. recently announced they...
February 27, 2011